CVE-2025-30042The CGM CLININET system provides smart card authentication; however, authentication is conducted locally on the client device, and, in reality, only the certificate number is used for access verifica…
Updated under an hour ago ()
Does this affect you?
It affects cgm clininet. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
The CGM CLININET system provides smart card authentication; however, authentication is conducted locally on the client device, and, in reality, only the certificate number is used for access verification. As a result, possession of the certificate number alone is sufficient for authentication, regardless of the actual presence of the smart card or ownership of the private key.
- CVSS
- 7.8 HIGH (v3.1, NVD)CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-603
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Analyzed
- Record last updated
- Jun 17, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
cgm clininet cgm:clininet | before 2025.ms2 | NVD |
References
- https://cert.pl/en/posts/2026/03/CVE-2025-10350/third-party-advisory
- https://www.cgm.com/pol_pl/products/szpital/cgm-clininet.htmlproduct
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.